BACKGROUND: The thickness of the cortical mantle is a sensitive measure for identifying alterations in cortical structure. We aimed to explore whether first episode schizophrenia patients already show a significant cortical thinning and whether cortical thickness anomalies may significantly influence clinical and cognitive features. METHOD: We investigated regional changes in cortical thickness in a large and heterogeneous sample of schizophrenia spectrum patients (n=142) at their first break of the illness and healthy controls (n=83). Magnetic resonance imaging brain scans (1.5 T) were obtained and images were analyzed by using brains2. The contribution of sociodemographic, cognitive and clinical characterictics was investigated. RESULTS: Patients showed a significant total cortical thinning (F=17.55, d=-0.62, p<0.001) and there was a diffuse pattern of reduced thickness (encompassing frontal, temporal and parietal cortices) (all p's<0.001, d's>0.53). No significant group×gender interactions were observed (all p's>0.15). There were no significant associations between the clinical and pre-morbid variables and cortical thickness measurements (all r's<0.12). A weak significant negative correlation between attention and total (r=-0.24, p=0.021) and parietal cortical thickness (r=-0.27, p=0.009) was found in patients (thicker cortex was associated with lower attention). Our data revealed a similar pattern of cortical thickness changes related to age in patients and controls. CONCLUSIONS: Cortical thinning is independent of gender, age, age of onset and duration of the illness and does not seem to significantly influence clinical and functional symptomatology. These findings support a primary neurodevelopment disorder affecting the normal cerebral cortex development in schizophrenia.
BACKGROUND: The thickness of the cortical mantle is a sensitive measure for identifying alterations in cortical structure. We aimed to explore whether first episode schizophreniapatients already show a significant cortical thinning and whether cortical thickness anomalies may significantly influence clinical and cognitive features. METHOD: We investigated regional changes in cortical thickness in a large and heterogeneous sample of schizophrenia spectrum patients (n=142) at their first break of the illness and healthy controls (n=83). Magnetic resonance imaging brain scans (1.5 T) were obtained and images were analyzed by using brains2. The contribution of sociodemographic, cognitive and clinical characterictics was investigated. RESULTS:Patients showed a significant total cortical thinning (F=17.55, d=-0.62, p<0.001) and there was a diffuse pattern of reduced thickness (encompassing frontal, temporal and parietal cortices) (all p's<0.001, d's>0.53). No significant group×gender interactions were observed (all p's>0.15). There were no significant associations between the clinical and pre-morbid variables and cortical thickness measurements (all r's<0.12). A weak significant negative correlation between attention and total (r=-0.24, p=0.021) and parietal cortical thickness (r=-0.27, p=0.009) was found in patients (thicker cortex was associated with lower attention). Our data revealed a similar pattern of cortical thickness changes related to age in patients and controls. CONCLUSIONS: Cortical thinning is independent of gender, age, age of onset and duration of the illness and does not seem to significantly influence clinical and functional symptomatology. These findings support a primary neurodevelopment disorder affecting the normal cerebral cortex development in schizophrenia.
Authors: Vincent A Magnotta; Greg Harris; Nancy C Andreasen; Daniel S O'Leary; William T C Yuh; Dan Heckel Journal: Comput Med Imaging Graph Date: 2002 Jul-Aug Impact factor: 4.790
Authors: Qi-Yong Gong; Vanessa Sluming; Andrew Mayes; Simon Keller; Thomas Barrick; Enis Cezayirli; Neil Roberts Journal: Neuroimage Date: 2005-05-01 Impact factor: 6.556
Authors: César González-Blanch; Benedicto Crespo-Facorro; Mario Alvarez-Jiménez; José Manuel Rodríguez-Sánchez; José María Pelayo-Terán; Rocío Pérez-Iglesias; José Luis Vázquez-Barquero Journal: J Psychiatr Res Date: 2006-10-17 Impact factor: 4.791
Authors: Laura C Wiegand; Simon K Warfield; James J Levitt; Yoshio Hirayasu; Dean F Salisbury; Stephan Heckers; Chandlee C Dickey; Ron Kikinis; Ferenc A Jolesz; Robert W McCarley; Martha E Shenton Journal: Biol Psychiatry Date: 2004-01-15 Impact factor: 13.382
Authors: Aaron L Goldman; Lukas Pezawas; Venkata S Mattay; Bruce Fischl; Beth A Verchinski; Qiang Chen; Daniel R Weinberger; Andreas Meyer-Lindenberg Journal: Arch Gen Psychiatry Date: 2009-05
Authors: Elizabeth R Sowell; Paul M Thompson; Suzanne E Welcome; Amy L Henkenius; Arthur W Toga; Bradley S Peterson Journal: Lancet Date: 2003-11-22 Impact factor: 79.321
Authors: Carl Christoph Schultz; Igor Nenadic; Brien Riley; Vladimir I Vladimirov; Gerd Wagner; Kathrin Koch; Claudia Schachtzabel; Thomas W Mühleisen; Buket Basmanav; Markus M Nöthen; Thomas Deufel; Michael Kiehntopf; Marcella Rietschel; Jürgen R Reichenbach; Sven Cichon; Ralf G M Schlösser; Heinrich Sauer Journal: Schizophr Bull Date: 2013-09-27 Impact factor: 9.306
Authors: Tyler A Lesh; Costin Tanase; Benjamin R Geib; Tara A Niendam; Jong H Yoon; Michael J Minzenberg; J Daniel Ragland; Marjorie Solomon; Cameron S Carter Journal: JAMA Psychiatry Date: 2015-03 Impact factor: 21.596
Authors: Carolina Makowski; John D Lewis; Claude Lepage; Ashok K Malla; Ridha Joober; Martin Lepage; Alan C Evans Journal: Cereb Cortex Date: 2019-12-17 Impact factor: 5.357